Davis HE, McCorkell L, Vogel JM, Topol EJ, Long COVID. Major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023. https://doi.org/10.1038/s41579-022-00846-2.

Article  PubMed  PubMed Central  Google Scholar 

Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, Perelman C, Sepulveda R, Rebolledo PA, et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12:9950.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akbarialiabad H, Taghrir MH, Abdollahi A, Ghahramani N, Kumar M, Paydar S, et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021;49:1163–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zimmermann P, Pittet LF, Curtis N. How common is long COVID in children and adolescents? Pediatr Infect Disease J. 2021;40:e482–7.

Article  Google Scholar 

Vahratian A, Adjaye-Gbewonyo D, Lin JS, Saydah S. Long COVID in Children: United States 2022. NCHS Data Brief. 2023.  https://www.cdc.gov/nchs/data/databriefs/db479.pdf

Re’em Y, Stelson EA, Davis HE, McCorkell L, Wei H, Assaf G, et al. Factors associated with psychiatric outcomes and coping in Long COVID. Nat Mental Health. 2023;1:361–72.

Article  Google Scholar 

Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416–27.

Article  PubMed  PubMed Central  Google Scholar 

Richard SA, Pollett SD, Fries AC, Berjohn CM, Maves RC, Lalani T, et al. Persistent COVID-19 symptoms at 6 months after onset and the role of Vaccination before or after SARS-CoV-2 infection. JAMA Netw Open. 2023;6:e2251360.

Article  PubMed  PubMed Central  Google Scholar 

The White House. Memorandum on Addressing the Long-Term Effects of COVID-19. The White House. 2022.https://www.whitehouse.gov/briefing-room/presidential-actions/2022/04/05/memorandum-on-addressing-the-long-term-effects-of-covid-19/#:~:text=My%20Administration%20recognizes%20the%20toll,Term%20Effects%20of%20COVID%2D19. (accessed 9 Oct2023).

Bevilacqua L, Fox-Smith L, Lewins A, Jetha P, Sideri A, Barton G, et al. Impact of COVID-19 on the mental health of children and young people: an umbrella review. J Epidemiol Community Health. 2023;77:704–9.

Article  PubMed  Google Scholar 

Amill-Rosario A, Lee H, Zhang C, dosReis S. Psychotropic prescriptions during the COVID-19 pandemic among U.S. Children and Adolescents Receiving Mental Health Services. J Child Adolesc Psychopharmacol. 2022;32:408–14.

Article  PubMed  Google Scholar 

Benistand P, Vorilhon P, Laporte C, Bouillon-Minois J-B, Brousse G, Bagheri R, et al. Effect of the COVID-19 pandemic on the psychotropic drug consumption. Front Psychiatry. 2022;13:1020023.

Article  PubMed  PubMed Central  Google Scholar 

Madigan S, Racine N, Vaillancourt T, Korczak DJ, Hewitt JMA, Pador P, et al. Changes in depression and anxiety among children and adolescents from before to during the COVID-19 pandemic: a systematic review and Meta-analysis. JAMA Pediatr. 2023;177:567.

Article  PubMed  PubMed Central  Google Scholar 

Racine N, McArthur BA, Cooke JE, Eirich R, Zhu J, Madigan S. Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a Meta-analysis. JAMA Pediatr. 2021;175:1142.

Article  PubMed  Google Scholar 

Tiger M, Wesselhoeft R, Karlsson P, Handal M, Bliddal M, Cesta CE, et al. Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic in Scandinavia. J Affect Disord. 2023;323:292–8.

Article  CAS  PubMed  Google Scholar 

Wolf K, Schmitz J. Scoping review: longitudinal effects of the COVID-19 pandemic on child and adolescent mental health. Eur Child Adolesc Psychiatry. 2023. https://doi.org/10.1007/s00787-023-02206-8.

Article  PubMed  PubMed Central  Google Scholar 

Bonnet U, Juckel G. COVID-19 outcomes: does the use of psychotropic drugs make a difference? Accumulating evidence of a beneficial effect of Antidepressants—A scoping review. J Clin Psychopharmacol. 2022;42:284–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oskotsky T, Marić I, Tang A, Oskotsky B, Wong RJ, Aghaeepour N, et al. Mortality risk among patients with COVID-19 prescribed selective serotonin reuptake inhibitor antidepressants. JAMA Netw Open. 2021;4:e2133090.

Article  PubMed  PubMed Central  Google Scholar 

Stewart TG, Rebolledo PA, Mourad A, Lindsell CJ, Boulware DR, McCarthy MW, et al. Higher-dose fluvoxamine and Time to sustained recovery in outpatients with COVID-19: the ACTIV-6 Randomized Clinical Trial. JAMA. 2023;330:2354.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Komodo Health. Komodo Homepage. https://www.komodohealth.com/ (accessed 24 Oct2023).

McGrath LJ, Scott AM, Surinach A, Chambers R, Benigno M, Malhotra D. Use of the Postacute Sequelae of COVID-19 diagnosis code in routine clinical practice in the US. JAMA Netw Open. 2022;5:e2235089.

Article  PubMed  PubMed Central  Google Scholar 

Samji H, Wu J, Ladak A, Vossen C, Stewart E, Dove N, et al. Review: Mental health impacts of the COVID-19 pandemic on children and youth–a systematic review. Child Adoles Ment Health. 2022;27:173–89.

Article  Google Scholar 

Rothe J, Buse J, Uhlmann A, Bluschke A, Roessner V. Changes in emotions and worries during the Covid-19 pandemic: an online-survey with children and adults with and without mental health conditions. Child Adolesc Psychiatry Ment Health. 2021;15:11.

Article  PubMed  PubMed Central  Google Scholar 

Stürmer T, Wyss R, Glynn RJ, Brookhart MA. Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs. J Intern Med. 2014;275:570–80.

Article  PubMed  PubMed Central  Google Scholar 

Bushnell G, Sun JW, dosReis S, Camelo Castillo W, Czaja AS, Durrieu G, et al. Geographic trends in Pediatric psychotropic medication dispensing before and after the start of the COVID-19 pandemic. PS. 2023;74:880–4.

Article  Google Scholar 

Thompson EJ, Stafford J, Moltrecht B, Huggins CF, Kwong ASF, Shaw RJ, et al. Psychological distress, depression, anxiety, and life satisfaction following COVID-19 infection: evidence from 11 UK longitudinal population studies. Lancet Psychiatry. 2022;9:894–906.

Article  PubMed  PubMed Central  Google Scholar 

Rao S, Lee GM, Razzaghi H, Lorman V, Mejias A, Pajor NM, et al. Clinical features and Burden of Postacute Sequelae of SARS-CoV-2 infection in children and adolescents. JAMA Pediatr. 2022;176:1000.

Article  PubMed  PubMed Central  Google Scholar 

Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. Risk factors Associated with Post– COVID-19 Condition: a systematic review and Meta-analysis. JAMA Intern Med. 2023;183:566.

Article  PubMed  PubMed Central  Google Scholar 

Kennelly CE, Nguyen ATP, Sheikhan NY, Strudwick G, Ski CF, Thompson DR, et al. The lived experience of long COVID: a qualitative study of mental health, quality of life, and coping. PLoS ONE. 2023;18:e0292630.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Au L, Capotescu C, Eyal G, Finestone G. Long covid and medical gaslighting: dismissal, delayed diagnosis, and deferred treatment. SSM - Qualitative Res Health. 2022;2:100167.

Article  Google Scholar 

Wong AC, Devason AS, Umana IC, Cox TO, Dohnalová L, Litichevskiy L, et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023;186:4851–e486720.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fritz BA, Hoertel N, Lenze EJ, Jalali F, Reiersen AM. Association between antidepressant use and ED or hospital visits in outpatients with SARS-CoV-2. Transl Psychiatry. 2022;12:341.

Article  CAS  PubMed  PubMed Central  Googl